BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16903909)

  • 1. FOXP3 ensembles in T-cell regulation.
    Li B; Samanta A; Song X; Furuuchi K; Iacono KT; Kennedy S; Katsumata M; Saouaf SJ; Greene MI
    Immunol Rev; 2006 Aug; 212():99-113. PubMed ID: 16903909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deacetylase inhibition promotes the generation and function of regulatory T cells.
    Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
    Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of Foxp3 in regulatory T cells.
    Haiqi H; Yong Z; Yi L
    Immunobiology; 2011 Jun; 216(6):678-85. PubMed ID: 21122941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
    Wan YY; Flavell RA
    Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.
    Zheng Y; Josefowicz SZ; Kas A; Chu TT; Gavin MA; Rudensky AY
    Nature; 2007 Feb; 445(7130):936-40. PubMed ID: 17237761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors.
    Lucas JL; Mirshahpanah P; Haas-Stapleton E; Asadullah K; Zollner TM; Numerof RP
    Cell Immunol; 2009; 257(1-2):97-104. PubMed ID: 19358983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer.
    Tone Y; Furuuchi K; Kojima Y; Tykocinski ML; Greene MI; Tone M
    Nat Immunol; 2008 Feb; 9(2):194-202. PubMed ID: 18157133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
    An W
    Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppression.
    Li B; Greene MI
    Immunology; 2008 Jan; 123(1):17-9. PubMed ID: 18154614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
    Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
    Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxp3-dependent programme of regulatory T-cell differentiation.
    Gavin MA; Rasmussen JP; Fontenot JD; Vasta V; Manganiello VC; Beavo JA; Rudensky AY
    Nature; 2007 Feb; 445(7129):771-5. PubMed ID: 17220874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP3+ regulatory T cells: Current controversies and future perspectives.
    Banham AH; Powrie FM; Suri-Payer E
    Eur J Immunol; 2006 Nov; 36(11):2832-6. PubMed ID: 17051620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for HDAC inhibitor therapy in autoimmunity and transplantation.
    Hancock WW
    Handb Exp Pharmacol; 2011; 206():103-23. PubMed ID: 21879448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.
    Zhang L; Zhao Y
    J Cell Physiol; 2007 Jun; 211(3):590-7. PubMed ID: 17311282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.
    Kitoh A; Ono M; Naoe Y; Ohkura N; Yamaguchi T; Yaguchi H; Kitabayashi I; Tsukada T; Nomura T; Miyachi Y; Taniuchi I; Sakaguchi S
    Immunity; 2009 Oct; 31(4):609-20. PubMed ID: 19800266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy.
    Lunke S; El-Osta A
    J Neurochem; 2009 Jun; 109(6):1557-69. PubMed ID: 19383090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
    Mor A; Keren G; Kloog Y; George J
    Eur J Immunol; 2008 Jun; 38(6):1493-502. PubMed ID: 18461565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.